{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services#webpage",
"url": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services",
"name": "Supporting Patient Retention in a Rare Disease Program with Fortrea Mobile Clinical Services",
"description": "This Fortrea case study explores how patient retention in rare disease trials was strengthened through Mobile Clinical Services and patient-centric support strategies across a global rare disease clinical program. The study involved six Phase I–III rare disease trials requiring biweekly in-home infusion treatments for patients across 14 countries, creating operational challenges related to patient adherence, travel burden, and continuity of participation throughout the study lifecycle. The case study highlights how Mobile Clinical Services supported rare disease trials through in-home infusion services, home visits, patient-centric support, and coordinated clinical operations designed to reduce participation burden and improve retention outcomes. Fortrea managed central pharmacy coordination, cold-chain logistics, investigational product distribution, and specialty courier oversight to maintain treatment stability and protocol compliance across participating regions. By integrating patient-centric support with in-home infusion management, clinical operations coordination, and global logistics support, the approach strengthened patient adherence and supported long-term patient retention throughout rare disease trial activities."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Supporting Patient Retention in a Rare Disease Program with Fortrea Mobile Clinical Services",
"item": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services#webpage"
},
"headline": "Patient Retention in Rare Disease Trials Using Mobile Clinical Services | Fortrea Case Study",
"description": "This Fortrea case study explores how an ultra-rare disease clinical trial was successfully delivered within a competitive rare disease trial landscape during a global Phase III This Fortrea case study explores how patient retention in rare disease trials was strengthened through Mobile Clinical Services and patient-centric support strategies across a global rare disease clinical program. The study involved six Phase I–III rare disease trials requiring biweekly in-home infusion treatments for patients across 14 countries, creating operational challenges related to patient adherence, travel burden, and continuity of participation throughout the study lifecycle. The case study highlights how Mobile Clinical Services supported rare disease trials through in-home infusion services, home visits, patient-centric support, and coordinated clinical operations designed to reduce participation burden and improve retention outcomes. Fortrea managed central pharmacy coordination, cold-chain logistics, investigational product distribution, and specialty courier oversight to maintain treatment stability and protocol compliance across participating regions. By integrating patient-centric support with in-home infusion management, clinical operations coordination, and global logistics support, the approach strengthened patient adherence and supported long-term patient retention throughout rare disease trial activities.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-02-03",
"dateModified": "2026-02-03",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-02/patient-retention-rare-disease-fortrea-mobile.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services#webpage",
"url": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services",
"name": "Supporting Patient Retention in a Rare Disease Program with Fortrea Mobile Clinical Services",
"description": "This Fortrea case study explores how patient retention in rare disease trials was strengthened through Mobile Clinical Services and patient-centric support strategies across a global rare disease clinical program. The study involved six Phase I–III rare disease trials requiring biweekly in-home infusion treatments for patients across 14 countries, creating operational challenges related to patient adherence, travel burden, and continuity of participation throughout the study lifecycle. The case study highlights how Mobile Clinical Services supported rare disease trials through in-home infusion services, home visits, patient-centric support, and coordinated clinical operations designed to reduce participation burden and improve retention outcomes. Fortrea managed central pharmacy coordination, cold-chain logistics, investigational product distribution, and specialty courier oversight to maintain treatment stability and protocol compliance across participating regions. By integrating patient-centric support with in-home infusion management, clinical operations coordination, and global logistics support, the approach strengthened patient adherence and supported long-term patient retention throughout rare disease trial activities."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Supporting Patient Retention in a Rare Disease Program with Fortrea Mobile Clinical Services",
"item": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/supporting-patient-retention-rare-disease-program-fortrea-mobile-clinical-services#webpage"
},
"headline": "Patient Retention in Rare Disease Trials Using Mobile Clinical Services | Fortrea Case Study",
"description": "This Fortrea case study explores how an ultra-rare disease clinical trial was successfully delivered within a competitive rare disease trial landscape during a global Phase III This Fortrea case study explores how patient retention in rare disease trials was strengthened through Mobile Clinical Services and patient-centric support strategies across a global rare disease clinical program. The study involved six Phase I–III rare disease trials requiring biweekly in-home infusion treatments for patients across 14 countries, creating operational challenges related to patient adherence, travel burden, and continuity of participation throughout the study lifecycle. The case study highlights how Mobile Clinical Services supported rare disease trials through in-home infusion services, home visits, patient-centric support, and coordinated clinical operations designed to reduce participation burden and improve retention outcomes. Fortrea managed central pharmacy coordination, cold-chain logistics, investigational product distribution, and specialty courier oversight to maintain treatment stability and protocol compliance across participating regions. By integrating patient-centric support with in-home infusion management, clinical operations coordination, and global logistics support, the approach strengthened patient adherence and supported long-term patient retention throughout rare disease trial activities.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-02-03",
"dateModified": "2026-02-03",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-02/patient-retention-rare-disease-fortrea-mobile.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
Case Study